Today March 28 the Swedish market close at 13.00. Danish and Norweigan markets is closed.

AcuCort is a biotechnology company. The company has developed and commercializes the drug Zeqmelit, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in, for instance, severe and acute allergic reactions. Zeqmelit is approved in Sweden, Denmark and Norway. The goal is global commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.

Quotes for AcuCort AB

Right Now

+/-
0.032
%
5,63%
Latest
0.6
High
0.7
Low
0.508
Volume
1 527 093
Turnover (SEK)
880 598
Market Value (MSEK)
50,4
Time (Latest trade)
2024-03-28 12:59

Board

CEO

  • Jonas Jönmark

Chairperson of the Board

  • Ebba Fåhraeus

Board

  • Alexandra Johnsson
  • Anna Eriksrud
  • Göran Tornling
  • Monica Wallter

Videos

Largest Owners

Name Capital % Votes % Date
Nordic Underwriting Aps 16,57 16,57 2023-12-27
Aqilion AB 13,50 13,50 2023-12-27
Avanza Pension 7,52 7,52 2023-12-27
Zoya Invest AB 5,28 5,28 2023-12-27
Formue Nord A/S 3,17 3,17 2023-12-27
Olle Florén med bolag 3,15 3,15 2023-12-27
Erik Fällström via bolag 2,66 2,66 2023-12-27
Alexander Svensson 2,09 2,09 2023-12-27
Nordnet Pensionsförsäkring 2,05 2,05 2023-12-27
Johan Thorell 1,27 1,27 2023-12-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-04-26 Delårsrapport 2024-Q1

  • 2024-06-04 Årsstämma 2023

  • 2024-08-23 Delårsrapport 2024-Q2

  • 2024-11-22 Delårsrapport 2024-Q3